Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Free Cash Flow: 2019-2025

Historic Free Cash Flow for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $11.7 million.

  • Eton Pharmaceuticals' Free Cash Flow rose 297.76% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 897.34%. This contributed to the annual value of $943,000 for FY2024, which is 86.16% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Free Cash Flow stood at $11.7 million for Q3 2025, which was up 47.53% from $8.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Free Cash Flow's 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of -$5.1 million in Q4 2021.
  • For the 3-year period, Eton Pharmaceuticals' Free Cash Flow averaged around $2.7 million, with its median value being $1.3 million (2024).
  • Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 763.96% in 2022, then tumbled by 300.78% in 2024.
  • Eton Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$5.1 million in 2021, then surged by 155.22% to $2.8 million in 2022, then tumbled by 86.32% to $387,000 in 2023, then slumped by 300.78% to -$777,000 in 2024, then spiked by 297.76% to $11.7 million in 2025.
  • Its Free Cash Flow stands at $11.7 million for Q3 2025, versus $8.0 million for Q2 2025 and $2.1 million for Q1 2025.